Research Article
Resveratrol Ameliorates Experimental Alcoholic Liver Disease by Modulating Oxidative Stress
Figure 4
Hepatic malondialdehyde (MDA) at the end of chronic alcohol administration for 16 weeks with resveratrol. Groups are the same as Figure 1. Data represent mean ± SD of 5 individual values. versus alcohol group.